NKTR Drug delivery Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company

NKTR 58.00

+3.6%

Nov 10 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: idos who wrote (346)	3/15/2011 7:15:23 PM
From: ghmm	Read Replies (2) of 507

Anyone have thoughts on the Phase 2 Ovarian data seen thus-far? I hope I am wrong but don't see the data being strong enough for a single arm accelerated approval. I was trying to speculate if the company possibly expanded enrollment for another reason (get more data to go into Phase 3, attract a partner) but I think they are really shooting for the accelerated approval. If anyone has links to studies/meta analysis of this patient population would appreciate any links.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next